These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8836823)

  • 1. Nephrogenic diabetes insipidus associated with foscarnet--a case report.
    Conn J; Colman P; Brown G; Street A; Bate K
    J Antimicrob Chemother; 1996 Jun; 37(6):1179-81. PubMed ID: 8836823
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy.
    Navarro JF; Quereda C; Quereda C; Gallego N; Antela A; Mora C; Ortuno J
    Am J Kidney Dis; 1996 Mar; 27(3):431-4. PubMed ID: 8604715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
    Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
    AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
    [No Abstract]   [Full Text] [Related]  

  • 4. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brighter future for the AIDS patient.
    Lowell E; Van Tassell B
    Insight; 2002; 27(4):95-6. PubMed ID: 12520982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present status and advances in pharmacotherapy for cytomegalovirus retinitis associated with acquired immunodeficiency syndrome].
    Wang WW; Ye JJ
    Zhonghua Yan Ke Za Zhi; 2010 Dec; 46(12):1148-52. PubMed ID: 21211231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in treatment for cytomegalovirus retinitis.
    Bowers M
    BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of crystals in kidneys of AIDS patients treated with foscarnet.
    Maurice-Estepa L; Daudon M; Katlama C; Jouanneau C; Sazdovitch V; Lacour B; Beaufils H
    Am J Kidney Dis; 1998 Sep; 32(3):392-400. PubMed ID: 9740154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of a case of aggressive cytomegalovirus retinitis in an infant with AIDS.
    Tejada P; Sarmiento B; Ramos JT; Saavedra J
    Int Ophthalmol; 1996-1997; 20(6):333-7. PubMed ID: 9237135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status of the management of cytomegalovirus retinitis in patients with AIDS].
    López-Cortés LF; Pachón-Díaz J
    Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):137-41. PubMed ID: 8695680
    [No Abstract]   [Full Text] [Related]  

  • 13. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
    Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus retinitis: new developments in prophylaxis and therapy.
    Jacobson MA
    AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy improves CMV treatment.
    AIDS Alert; 1996 Mar; 11(3):32-3. PubMed ID: 11363244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
    Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient foscarnet-induced hypercalcaemia.
    Barba R; Gómez-Rodrigo J; Marco J; Espejo M; Mena D
    AIDS; 1998 Oct; 12(14):1930-1. PubMed ID: 9792397
    [No Abstract]   [Full Text] [Related]  

  • 18. Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group.
    Carosi G; Castelli F; Lernestedt JO; Antoniazzi E; Gerna G
    AIDS; 1997 Feb; 11(2):258-60. PubMed ID: 9030380
    [No Abstract]   [Full Text] [Related]  

  • 19. Detecting CMV retinitis: know what to look for. Treatment is effective but not pleasant.
    AIDS Alert; 1996 Mar; 11(3):suppl 1-2. PubMed ID: 11363248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphonoformate for CMV retinitis in AIDS.
    Colucciello M
    Am J Med; 1995 Mar; 98(3):317-8. PubMed ID: 7872354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.